$PLTR

Wall Street Is Warming Up to Palantir

Palantir (PLTR) rose 1% premarket after Barclays initiated coverage with an Overweight rating and $265 price target, citing competitive advantages and growth. Goldman Sachs also upgraded the stock to Buy with a $230 target. Analysts highlight strong AI demand and profitability, but note execution risks. TipRanks shows a Moderate Buy consensus.

Original reporting
Published Oct 9, 2026, 6:53 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 9, 2026, 7:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$PLTR
Bullish
high confidence
Mentioned
$PLTR
Relevance
7/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$PLTRBullishMed
01

Why it matters

The dual upgrades provide fresh catalyst for short‑term buying, especially ahead of the market open.

02

Market read

Analyst upgrades are a primary driver of intraday price moves; this article introduces the first Barclays coverage, making it actionable for traders.

03

What to watch

Potential regulatory scrutiny of AI data practices could temper upside.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

Barclays and Goldman Sachs have both upgraded Palantir, signaling renewed analyst confidence in its AI platform and defense‑tech exposure.

Company-level read

Ticker impact

$PLTRBullishHigh confidence
Context

Barclays initiated coverage with an Overweight rating and a $265 price target, prompting a >1% pre‑market rise.

Expected impact

upward pressure as investors price in the new target

Evidence & confidence

The upgrade is the first report of Barclays coverage and includes a concrete price target, which typically drives buying interest.

Market effects

Boosts sentiment toward AI and data‑analytics stocks as coverage expands.

Primarily U.S. equity market, limited broader regional effect.

Modest; reflects growing optimism in the global AI sector.

Counterpoint

Some investors may view the high target as overly optimistic given Palantir's profitability challenges.

Key entities

  • Barclays

    Initiated coverage with Overweight rating and $265 target.

  • Goldman Sachs

    Raised rating to Buy with $230 target.

Related articles

$BAMed

Aerospace and defense stocks offer opportunity, Barclays says in launching coverage

Barclays launched coverage of 20 aerospace and defense companies, rating Boeing (BA) and RTX (RTX) Overweight. Analyst Anthony Valentini expects Boeing to return to normalized growth and RTX to benefit from new aircraft content and missile exposure. Other Overweight picks include Rocket Lab (RKLB), CAE (CAE), DPC (DDPC), Kratos (KTOS), Karman (KRMN), Archer Aviation (ACHR), Beta Technologies (BETA), SpaceX (SPCX), and Palantir (PLTR).

$PLTRMed

Goldman Predicts a “Step Function Change” in Palantir’s AI Opportunity

Goldman Sachs upgraded Palantir (PLTR) to Buy with a $230 price target, citing growth in sovereign AI, bespoke software, and industry-specific sales. Analyst Gabriela Borges expects revenue to nearly quadruple by fiscal 2028. The stock trades at 102.4x forward earnings, near its five-year average. Goldman notes Palantir's operating margin improved from -26.7% in 2021 to 31.6% in 2025.

$PLTRMed

How Much Growth Are You Paying For In Palantir Stock?

Palantir (PLTR) stock rose 57% in three months, outpacing the S&P 500. Goldman Sachs upgraded it to buy. Trading at 158.1x P/E, investors expect significant profit growth. Revenue grew 93% YoY in Q2 2026, driven by U.S. commercial sales. Management aims to sustain this growth. Q3 2026 revenue guidance is $2.16B-$2.164B. International growth is weaker, and the stock is volatile during market downturns.

$PLTRHigh

Palantir Stocks Rise 2.4% as Goldman Backs Sovereign AI

Palantir Technologies (PLTR) shares rose 2.4% to $203.57 after Goldman Sachs upgraded its rating to Buy with a $230 price target. The upgrade was driven by sovereign AI demand, with U.S. government revenue up 90% to $809 million in Q2. The company also raised its full-year U.S. commercial revenue outlook above $3.424 billion. However, shares are 10% above the GF Value estimate, leaving less room for execution errors.